The role of α₁-adrenergic receptors in regulating metabolism: increased glucose tolerance, leptin secretion and lipid oxidation

References

• Perez DM, Doze VA. Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypes. J Recept Signal Transduct Res 2011;31:98–110.
   PubMed Web of Science ®Google Scholar
• Stark B, Keller U. Alpha 1-adrenergic stimulation of ketogenesis and fatty acid oxidation is associated with inhibition of lipogenesis in rat hepatocytes. Experientia 1987;43:1104–6.
   PubMedGoogle Scholar
• Brindle NPJ, Ontko JA. α-adrenergic suppression of very-low-density-lipoprotein triacylglycerol secretion by isolated rat hepatocytes. Biochem J 1988;250:363–8.
   PubMed Web of Science ®Google Scholar
• Hutchinson DS, Bengtsson T. α1A-adrenoceptors activate glucose uptake in L6 muscle cells through a phospholipase C-, phosphatidylinositol-3 kinase-, and atypical protein kinase C-dependent pathway. Endocrinology 2005;146:901–12.
   PubMed Web of Science ®Google Scholar
• Hutchinson DS, Bengtsson T. AMP-activated protein kinase activation by adrenoceptors in L6 skeletal muscle cells: mediation by alpha1-adrenoceptors causing glucose uptake. Diabetes 2006;55:682–90.
   PubMed Web of Science ®Google Scholar
• Liu IM, Tsai CC, Lai TY, Cheng JT. Stimulatory effect of isoferulic acid on a1A-adrenoceptor to increase glucose uptake into cultured myoblast C2C12 cell of mice. Auton Neurosci 2001;88:175–80.
   PubMed Web of Science ®Google Scholar
• Burcelin R, Uldry M, Foretz M, et al. Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype. J Biol Chem 2004;279:1108–15.
   PubMed Web of Science ®Google Scholar
• Lafontan M, Barbe P, Galitzky J, et al. Adrenergic regulation of adipocyte metabolism. Hum Reprod 1997;12:6–20.
   PubMedGoogle Scholar
• Mauriège P, Pergola GD, Berlan M, Lafontan M. Human fat cell β-adrenergic receptors: β agonist-dependent lipolytic responses and characterization of β-adrenergic binding sites on human fat cell membranes with highly selective β1-antagonists. J Lipid Res 1988;29:587–601.
   PubMed Web of Science ®Google Scholar
• Tavernier G, Jimenez M, Giacobino JP, et al. Norepinephrine induces lipolysis in beta1/beta2/beta3-adrenoceptor knockout mice. Mol Pharmacol 2005;68:793–9.
   PubMed Web of Science ®Google Scholar
• Fagerholm V, Haaparanta M, Scheinin M. α2-Adrenoceptor regulation of blood glucose homeostasis. Basic Clin Pharmacol Toxicol 2011;108:365–70.
   PubMed Web of Science ®Google Scholar
• Lafontan M, Berlan M. Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocr Rev 1995;16:716–38.
   PubMed Web of Science ®Google Scholar
• Sugden MC, Tordoff AF, Ilic V, Williamson DH. α-adrenergic stimulation of [1–14C]oleate oxidation to 14CO2 in isolated rat hepatocytes. FEBS Lett 1980;120:80–4.
   PubMed Web of Science ®Google Scholar
• Kosugi K, Harano Y, Nakano T, et al. Mechanism of adrenergic stimulation of hepatic ketogenesis. Metab Clin Exp 1983;32:1081–7.
   PubMed Web of Science ®Google Scholar
• Oberhaensli RD, Schwendimann R, Keller U. Effect of norepinephrine on ketogenesis, fatty acid oxidation, and esterification in isolated rat hepatocytes. Diabetes 1985;34:774–9.
   PubMed Web of Science ®Google Scholar
• Nomura T, Nomura Y, Tachibana M, et al. Alpha 1-adrenergic regulation of ketogenesis in isolated rat hepatocytes. Biochim Biophys Acta 1991;1092:94–100.
   PubMed Web of Science ®Google Scholar
• Zuscik MJ, Sand S, Ross SA, et al. Overexpression of the alpha 1B-adrenergic receptor causes apoptotic neurodegeneration: a multiple system atrophy. Nat Med 2000;6:1388–94.
   PubMed Web of Science ®Google Scholar
• Rorabaugh BR, Ross SA, Gaivin RJ, et al. α1A- but not a1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism. Cardiovasc Res 2005;65:436–45.
   PubMed Web of Science ®Google Scholar
• O'Connell TD, Ishizaka S, Nakamura A, et al. The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J Clin Invest 2003;111:1783–91.
   PubMed Web of Science ®Google Scholar
• O'Connell TD, Swigart PM, Rodrigo MC, et al. α1-Adrenergic receptors prevent a maladaptive cardiac response to pressure overload. J Clin Invest 2006;116:1005–15.
   PubMed Web of Science ®Google Scholar
• Millward CA, Desantis D, Hsieh CW, et al. Phosphoenolpyruvate carboxykinase (Pck1) in hepatic and adipose tissue contributes to the regulation of the triglyceride fatty acid cycle and development of insulin resistance in mice. J Lipid Res 2010;51:1452–63.
   PubMed Web of Science ®Google Scholar
• Millward CA, Heaney JD, Sinasac DS, et al. Mice with a deletion in the gene for CCAAT/enhancer-binding protein beta are protected against diet-induced obesity. Diabetes 2007;56:161–7.
   PubMed Web of Science ®Google Scholar
• Ferré P, Leturque A, Burnol AF, et al. A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat. Biochem J 1985;228:103–10.
   PubMed Web of Science ®Google Scholar
• Shi T, Papay RS, Perez DM. α1A-Adrenergic receptor prevents cardiac ischemic damage through PKCδ/GLUT1/4-mediated glucose uptake. J Recept Signal Transduct Res 2016;36:261–70.
   PubMed Web of Science ®Google Scholar
• Simonson DC, DeFronzo RA. Indirect calorimetry: methodological and interpretative problems. Am J Physiol 1990;258:E399–412.
   PubMed Web of Science ®Google Scholar
• Zuscik MJ, Chalothorn D, Hellard D, et al. Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the a1B-adrenergic receptor. J Biol Chem 2001;276:13738–43.
   PubMed Web of Science ®Google Scholar
• Papay R, Zuscik MT, Ross SA, et al. Mice expressing the α1B-adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation. J Neurochem 2002;83:623–34.
   PubMed Web of Science ®Google Scholar
• Doze VA, Papay RS, Collette KM, et al. Long term α1A-adrenergic receptor stimulation improves synaptic plasticity, cognitive function, mood and longevity. Mol Pharmacol 2011;80:747–58.
   PubMed Web of Science ®Google Scholar
• Collette KM, Zhou XD, Amoth HM, et al. Long-term α1B-adrenergic receptor activation shortens lifespan while α1A-adrenergic receptor stimulation prolongs lifespan in association with decreased cancer incidence. Age (Dordr) 2014;36:9675–7.
   PubMed Web of Science ®Google Scholar
• Goto Y. Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial. Am J Med 1984;76:72–8.
   PubMed Web of Science ®Google Scholar
• Ferrara LA, Marotta T, Rubba P, et al. Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism. Am J Med 1986;80:104–8.
   PubMed Web of Science ®Google Scholar
• Ulahannan TJ1, Karpe F, Humphreys SM, et al. Effects of acute administration of doxazosin on fasting and postprandial haemodynamics and lipid metabolism in healthy subjects. Horm Metab Res 2002;34:499–503.
   PubMed Web of Science ®Google Scholar
• Flechtner-Mors M, Jenkinson CP, Alt A, et al. Sympathetic regulation of glucose uptake by the alpha1-adrenoceptor in human obesity. Obes Res 2004;12:612–20.
   PubMedGoogle Scholar
• Cheng JT, Liu IM, Yen ST, Chen PC. Role of a1A-adrenoceptor in the regulation of glucose uptake into white adipocyte of rats in vitro. Auton Neurosci 2000;84:140–6.
   PubMed Web of Science ®Google Scholar
• Havel PJ. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology 1998;139:551–8.
   PubMed Web of Science ®Google Scholar
• Halaas JL, Boozer C, Blair-West J, et al. Physiological response to long term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 1997;94:8878–83.
   PubMed Web of Science ®Google Scholar
• Campfield LA, Smith FJ, Guisez Y, et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546–9.
   PubMed Web of Science ®Google Scholar
• Miyamoto L, Ebihara K, Kusakabe T, et al. Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and α1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin. J Biol Chem 2012;287:40441–7.
   PubMed Web of Science ®Google Scholar
• Ihara S, Shimamoto K, Watanabe H, et al. An alpha 1-receptor blocker reduces plasma leptin levels in hypertensive patients with obesity and hyperleptinemia. Hypertens Res 2006;29:805–81.
   PubMed Web of Science ®Google Scholar
• Banks WA. Enhanced leptin transport across the blood–brain barrier by alpha 1-adrenergic agents. Brain Res 2001;899:209–17.
   PubMed Web of Science ®Google Scholar
• Ebihara K, Ogawa Y, Masuzaki H, et al. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 2001;50:1440–8.
   PubMed Web of Science ®Google Scholar
• Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002;109:1345–50.
   PubMed Web of Science ®Google Scholar
• Marti A, Novo FJ, Martinez-Anso E, et al. Leptin gene transfer into muscle increases lipolysis and oxygen consumption in white fat tissue in ob/ob mice. Biochem Biophys Res Commun 1998;246:859–62.
   PubMed Web of Science ®Google Scholar
• Minokoshi Y, Kahn BB. Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. Biochem Soc Trans 2003;31:196–201.
   PubMed Web of Science ®Google Scholar
• Minokoshi Y, Kim YB, Peroni OD, et al. Leptin stimulates fatty-acid oxidation by activating AMP activated protein kinase. Nature 2002;415:339–43.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Okamoto S, Lee S, et al. Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase. Mol Cell Biol 2007;27:4317–27.
   PubMed Web of Science ®Google Scholar
• Fruhbeck G, Aguado M, Martinez JA. In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun 1997;240:590–4.
   PubMed Web of Science ®Google Scholar
• Kamohara S, Burcelin R, Halaas JL, et al. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997;389:374–7.
   PubMed Web of Science ®Google Scholar
• Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997;272:10585–93.
   PubMed Web of Science ®Google Scholar
• Shimabukuro M, Koyama K, Chen G, et al. Beta-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. Diabetes 1997;46:1276–80.
   PubMed Web of Science ®Google Scholar
• Fruhbeck G, Aguado M, Gomez-Ambrosi J, Martinez JA. Lipolytic effect of in vivo leptin administration on adipocytes of lean and ob/ob mice, but not db/db mice. Biochem Biophys Res Commun 1998;250:99–102.
   PubMed Web of Science ®Google Scholar
• Papay R, Gaivin R, Archana J, et al. Localization of the mouse alpha1A-adrenergic receptor in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons and NG2 oligodendrocyte progenitors. J Comp Neurol 2006;497:209–22.
   PubMed Web of Science ®Google Scholar
• McGaffin KR, Witham WG, Yester KA, et al. Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice. Cardiovasc Res 2011;89:60–71.
   PubMed Web of Science ®Google Scholar
• Bouhidel O, Pons S, Souktani R, et al. Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol 2008;295:H1580–6.
   Google Scholar
• Smith CC, Mocanu MM, Davidson SM, et al. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol 2006;149:5–13.
   PubMed Web of Science ®Google Scholar
• Folch J, Pedrós I, Patraca I, et al. Neuroprotective and anti-ageing role of leptin. J Mol Endocrinol 2012;49:R149–56.
   Google Scholar
• Doenst T, Taegtmeyer H. alpha-Adrenergic stimulation mediates glucose uptake through phosphatidylinositol 3-kinase in rat heart. Circ Res 1999;84:467–74.
   PubMed Web of Science ®Google Scholar
• Angeloni C, Maraldi T, Ghelli A, et al. Green tea modulates alpha(1)-adrenergic stimulated glucose transport in cultured rat cardiomyocytes. J Agric Food Chem 2007;55:7553–8.
   PubMed Web of Science ®Google Scholar
• Manchester J, Kong X, Nerbonne J, et al. Glucose transport and phosphorylation in single cardiac myocytes: rate limiting steps in glucose metabolism. Am J Physiol Endocrinol Metab 1994;266:E326–33.
   PubMedGoogle Scholar
• Depre C, Vanoverschelde JL, Taegtmeyer H. Glucose for the heart. Circulation 1999;99:578–88.
   PubMed Web of Science ®Google Scholar
• Tian R, Abel ED. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation 2001;103:2961–6.
   PubMed Web of Science ®Google Scholar
• Zurlo F, Larson K, Bogardus C, Ravussin E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 1990;86:1423–7.
   PubMed Web of Science ®Google Scholar
• Ariano MA, Armstrong RB, Edgerton VR. Hindlimb muscle fiber populations of five mammals. J Histochem Cytochem 1973;21:51–5.
   PubMed Web of Science ®Google Scholar
• Petersen KF, Dufour S, Savage DB, et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA 2007;104:12587–94.
   PubMed Web of Science ®Google Scholar
• Arch JR. The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol 2008;378:225–40.
   PubMed Web of Science ®Google Scholar
• Blue DR, Daniels DV, Gever JR, et al. Pharmacological characteristics of Ro 115–1240, a selective α1A-AR partial agonist: a potential therapy for stress urinary incontinence. BJU Int 2004;93:162–70.
   PubMed Web of Science ®Google Scholar
• Modiri AR, Fredrickson MG, Gillberg PG, Alberts P. Selectivity of oxymetazoline for urethral pressure vs blood pressure in the anaesthetized female rabbit. Scand J Urol Nephrol 2000;34:151–6.
   PubMed Web of Science ®Google Scholar
• Musselman DM, Ford AP, Gennevois DJ, et al. A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence. BJU Int 2004;93:78–83.
   PubMed Web of Science ®Google Scholar
• DeWire SM, Violin JD. Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology. Circ Res 2011;109:205–16.
   PubMed Web of Science ®Google Scholar
• Evans BA, Broxton N, Merlin J, et al. Quantification of functional selectivity at the human α(1A)-adrenoceptor. Mol Pharmacol 2011;79:298–307.
   PubMed Web of Science ®Google Scholar